BIOMAT Database Logo BIOMAT Database Logo

In vitro and in vivo enhancement of ddI activity against Rauscher murine leukemia virus by ribavirin. 1995

L B Allen, and D C Quenelle, and L Westbrook, and B A Taylor, and M N Prichard, and A D Brazier, and M G Hollingshead, and W M Shannon
Microbiology Research Department, Southern Research Institute, Birmingham, AL 35205, USA.

Ribavirin has been reported to enhance the activity of ddI against HIV. We explored this enhancement of antiviral activity in Rauscher murine leukemia virus (RMuLV) models in vitro and in vivo. The significant finding in these studies was that combinations of the drugs exhibited virus titer reductions that were greater than would be expected if the drug interactions were simply additive. These effects were designated synergistic by the method of Prichard and Shipman (Prichard, M.N. and Shipman, C., Jr. (1990). A three-dimensional model to analyze drug-drug interaction, Antiviral Res. 14, 181-206). In addition to the antiviral synergy, we also observed some synergistic toxicity in the animal model.

UI MeSH Term Description Entries
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008297 Male Males
D011925 Rauscher Virus A strain of MURINE LEUKEMIA VIRUS associated with mouse tumors similar to those caused by the FRIEND MURINE LEUKEMIA VIRUS. It is a replication-competent murine leukemia virus. It can act as a helper virus when complexing with a defective transforming component, RAUSCHER SPLEEN FOCUS-FORMING VIRUS. Rauscher leukemia virus,Rauscher leukemia viruses,Virus, Rauscher,leukemia viruses, Rauscher
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012192 Retroviridae Infections Virus diseases caused by the RETROVIRIDAE. Retrovirus Infections,Infections, Retroviridae,Infections, Retrovirus,XMRV Infection,Xenotropic MuLV-related Virus Infection,Xenotropic Murine Leukemia Virus-related Virus Infection,Infection, Retroviridae,Infection, Retrovirus,Infection, XMRV,Infections, XMRV,Retroviridae Infection,Retrovirus Infection,XMRV Infections,Xenotropic MuLV related Virus Infection,Xenotropic Murine Leukemia Virus related Virus Infection
D012254 Ribavirin A nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses. Ribovirin,Tribavirin,ICN-1229,Rebetol,Ribamide,Ribamidil,Ribamidyl,Ribasphere,Vilona,Viramide,Virazide,Virazole,ICN 1229,ICN1229
D014412 Tumor Virus Infections Infections produced by oncogenic viruses. The infections caused by DNA viruses are less numerous but more diverse than those caused by the RNA oncogenic viruses. Fibroma, Shope,Papilloma, Shope,Infections, Tumor Virus,Infection, Tumor Virus,Shope Fibroma,Shope Papilloma,Tumor Virus Infection
D015430 Weight Gain Increase in BODY WEIGHT over existing weight. Gain, Weight,Gains, Weight,Weight Gains

Related Publications

L B Allen, and D C Quenelle, and L Westbrook, and B A Taylor, and M N Prichard, and A D Brazier, and M G Hollingshead, and W M Shannon
The activity of streptonigrin against the Rauscher murine leukemia virus in vivo.
April 1966, Cancer research,
L B Allen, and D C Quenelle, and L Westbrook, and B A Taylor, and M N Prichard, and A D Brazier, and M G Hollingshead, and W M Shannon
Enhancement of murine sarcoma virus (Moloney) infection and tumorigenesis in vivo by coinfection with Rauscher leukemia virus.
November 1969, Cancer research,
L B Allen, and D C Quenelle, and L Westbrook, and B A Taylor, and M N Prichard, and A D Brazier, and M G Hollingshead, and W M Shannon
Stimulation of murine lymphocytes by Rauscher leukemia virus in vitro.
January 1980, Journal of immunology (Baltimore, Md. : 1950),
L B Allen, and D C Quenelle, and L Westbrook, and B A Taylor, and M N Prichard, and A D Brazier, and M G Hollingshead, and W M Shannon
An ELISA system for evaluating antiretroviral activity against Rauscher murine leukemia virus.
June 1992, Antiviral research,
L B Allen, and D C Quenelle, and L Westbrook, and B A Taylor, and M N Prichard, and A D Brazier, and M G Hollingshead, and W M Shannon
Endodeoxyribonuclease activity associated with Rauscher murine leukemia virus.
January 1981, Journal of virology,
L B Allen, and D C Quenelle, and L Westbrook, and B A Taylor, and M N Prichard, and A D Brazier, and M G Hollingshead, and W M Shannon
Inhibition of Rauscher murine leukemia virus growth in vitro by actinomycin D.
June 1967, Virology,
L B Allen, and D C Quenelle, and L Westbrook, and B A Taylor, and M N Prichard, and A D Brazier, and M G Hollingshead, and W M Shannon
Synthesis of Rauscher murine leukemia virus-specific polypeptides in vitro.
February 1976, Proceedings of the National Academy of Sciences of the United States of America,
L B Allen, and D C Quenelle, and L Westbrook, and B A Taylor, and M N Prichard, and A D Brazier, and M G Hollingshead, and W M Shannon
In vitro and in vivo activity of ribavirin against Andes virus infection.
January 2011, PloS one,
L B Allen, and D C Quenelle, and L Westbrook, and B A Taylor, and M N Prichard, and A D Brazier, and M G Hollingshead, and W M Shannon
Blood aspartyl transcarbamylase activity in Rauscher virus induced murine leukemia.
January 1970, Haematologia,
L B Allen, and D C Quenelle, and L Westbrook, and B A Taylor, and M N Prichard, and A D Brazier, and M G Hollingshead, and W M Shannon
Spleen-derived Rauscher Murine Leukemia Virus.
November 1967, Applied microbiology,
Copied contents to your clipboard!